Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
CervoMed Inc. (NASDAQ : CRVO) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.
Quote
| Last: | $5.43 |
|---|---|
| Change Percent: | 41.04% |
| Open: | $4.68 |
| Close: | $3.85 |
| High: | $7.81 |
| Low: | $4.61 |
| Volume: | 92,101,241 |
| Last Trade Date Time: | 06/18/2026 12:45:42 pm |
Stock Data
| Market Cap: | $47,188,867 |
|---|---|
| Float: | 5,977,256 |
| Insiders Ownership: | 0.74% |
| Institutions: | 24 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.cervomed.com |
| Country: | US |
| City: | Boston |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about CervoMed Inc. (NASDAQ: CRVO).
